肿瘤预防与治疗2024，Vol.37Issue(4)：348-357,10.DOI:10.3969/j.issn.1674-0904.2024.04.011
晚期食管鳞癌治疗研究进展
Research Progress of the Treatment for Advanced Esophageal Squamous Cell Carcinoma
摘要
Abstract
Immunotherapy combined with chemotherapy has become the first-line treatment for advanced esophageal squa-mous cell carcinoma patients.However,issues such as low efficiency in overall population and profitability still exist.In re-cent years,many immune checkpoint inhibitors and targeted drugs have emerged,and significant research progress has been made in exploring new treatment modes,including immunotherapy combined with chemoradiotherapy,immunotherapy com-bined with targeted therapy,and dual immune checkpoint inhibitor therapy.This article provides a brief summary of relevant important research,hoping to provide new insights for the treatment of esophageal cancer.关键词
晚期食管癌/免疫治疗/靶向治疗/联合治疗/抗血管生成药物Key words
Advanced esophageal cancer/Immunotherapy/Targeted therapy/Combination therapy/Antiangiogenic drug分类
医药卫生引用本文复制引用
邢思远,孟祥瑞,单争争,王峰..晚期食管鳞癌治疗研究进展[J].肿瘤预防与治疗,2024,37(4):348-357,10.基金项目
This study was supported by National Natural Science Foundation of China(No.222300420557)and CSCO-Roche Cancer Research Foundation(No.Y-2019Roche-092),and by grants from Science and Technology Department of Henan Province(No.232102310343,No.222102310694).河南省自然科学基金面上项目(编号:222300420557) （No.222300420557）
希思科-罗氏肿瘤研究基金(2019年度)(编号:Y-2019Roche-092) （2019年度）
河南省科技攻关项目(编号:232102310343) （编号:232102310343）
河南省科技攻关项目(编号:222102310694) （编号:222102310694）
